Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today presented final first-in-human data for ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Replimune received rejections in ...
Thanks to a new collaboration, Replit is giving people a simpler way to make money with their vibe-coded apps and websites.
Vibe coding AI startup Replit launched an integration with Visa and a “white glove” customer support program for businesses ...
Visa has announced an undisclosed investment in AI coding platform Replit. The two companies are also exploring how to ...